Do you know when to advance patients with IBS-C from over-the-counter to prescription treatments?

Credit available for this activity expires: 04/22/2027
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-otc-cycle-optimizing-prescription-therapy-ibs-c-2026a1000bpz?ecd=bdc_podcast_libsyn_mscpedu

Are you confident in identifying the risk for recurrence in early-stage HR-positive, HER2-negative breast cancer?

Credit available for this activity expires: [04/21/27]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/challenging-confines-risk-recurrence-high-risk-hr-her2-early-2026a1000bq3?ecd=bdc_podcast_libsyn_mscpedu

Risk vs Biology: Which carries more weight in the decision to escalate therapy?

Credit available for this activity expires: 04/21/2027
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/lessons-real-world-treating-high-risk-hr-her2-breast-cancer-2026a1000bhd?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on the latest clinical developments for steroidal and nonsteroidal mineralocorticoid receptor antagonists (MRAs) in heart failure with preserved ejection fraction (HFpEF)?

Credit available for this activity expires: 04/08/2027
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-headlines-critical-look-mra-evidence-hfpef-2026a1000al7?ecd=bdc_podcast_libsyn_mscpedu

Did you know that antibody-drug conjugates (ADCs) targeting Trop2 have demonstrated significant clinical potential for patients with TNBC?

Credit available for this activity expires: 4/8/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/front-antibody-drug-conjugates-shifting-paradigm-metastatic-2026a1000a9z?ecd=bdc_podcast_libsyn_mscpedu

Your patient asks, "Will switching to a biosimilar make my disease worse?" Learn how to confidently address their concerns.

Credit available for this activity expires: 4/7/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003282?ecd=bdc_podcast_libsyn_mscpedu

Did you know prior CDK4/6 duration may be prognostic for identifying patients more likely to benefit from single-agent oral SERDs?

Credit available for this activity expires: 04/07/2027
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/enhancing-clinical-understanding-oral-serd-based-therapies-2026a1000a46?ecd=bdc_podcast_libsyn_mscpedu

Optimize every trial: Discover how strategic medication selection clarifies the surgical path and improves patient outcomes before intervention.

Credit available for this activity expires: 04/02/2027
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/maximizing-therapeutic-efficacy-prior-epilepsy-surgery-2026a10009oz?ecd=bdc_podcast_libsyn_mscpedu